Literature DB >> 6395141

Biochemical pharmacology of antiestrogen action.

V C Jordan.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6395141

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  66 in total

Review 1.  Solving the puzzle of hormone-dependent breast cancer.

Authors:  R J Santen
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

Review 2.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

3.  Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro.

Authors:  N D Arbuckle; S Dauvois; M G Parker
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

4.  Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.

Authors:  V Craig Jordan; Ramona Curpan; Philipp Y Maximov
Journal:  J Natl Cancer Inst       Date:  2015-04-02       Impact factor: 13.506

5.  Beyond raloxifene for the prevention of osteoporosis and breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  2006-11-20       Impact factor: 8.739

Review 6.  The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens.

Authors:  D A Tonetti; V C Jordan
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

Review 7.  Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.

Authors:  V Craig Jordan; Joan Lewis-Wambi; Helen Kim; Heather Cunliffe; Eric Ariazi; Catherine G N Sharma; Heather A Shupp; Ramona Swaby
Journal:  Breast       Date:  2007-08-24       Impact factor: 4.380

8.  Effect of in vivo antiestrogen pretreatment on rabbit atrial chronotropic response to histamine.

Authors:  S N Baksi; M J Hughes
Journal:  Agents Actions       Date:  1986-08

9.  Estrogenic effects of phenolphthalein on human breast cancer cells in vitro.

Authors:  P M Ravdin; M van Beurden; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

10.  Antiprogestagen RU486 prevents the LH-dependent decrease in the serum concentrations of inhibin in the rat.

Authors:  M Tébar; C Bellido; J T Uilenbroek; J E Sánchez-Criado
Journal:  Cell Mol Neurobiol       Date:  1996-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.